Skip to main content
. 2017 Mar 23;12(3):e0170361. doi: 10.1371/journal.pone.0170361

Table 2. Worldwide prevalence (95% CI) of metabolic syndrome in rheumatoid arthritis patients.

First Author Country Criteria DOP Age Range Mean Age Gender N. of RA Patients Prevalence of MetS in RA Patients (%) Reference
Total Male Female Total Male Female
Lee SH Korea AHA/NHLBI 2016 ≥12 63.6 Both 598 110 488 36.4 34.5 36.9 [37]
Hugo M France IDF 2016 18–75 57.6 Both 57 15 42 24.0 25.0 24.0 [38]
Zafar ZA Pakistan NCEP-ATP III 2016 20–60 43.8 Both 384 97 277 31.3 18.5 35.5 [35]
Oliveira BMGB Brazil NCEP-ATP III 2016 - 55.5 Female 107 - 107 51.4 - 51.4 [24]
Oliveira BMGB Brazil IDF 2016 - 55.5 Female 107 - 107 53.4 - 53.4 [24]
Muller R Estonia NCEP-ATP III 2016 - 51.6 Both 91 66 25 35 [33]
Dihingia P India NCEP-ATP III 2016 >12 41.5 Both 72 6 66 16.7 [39]
Ghazaly AHAH Egypt ATP III 2015 ≥18 40.7 Both 80 13 67 50.0 53.8 49.2 [40]
Salamon L Croatia ATP III 2015 52–68 59 Both 583 100 483 43.1 40.0 43.7 [41]
Tanayakom P Thailand NCEP-ATP III 2015 - 59 Both 267 31 236 16.1 12.9 16.5 [42]
Parra-Salcedo F Mexico AHA/NHLBI 2015 - 38.1 Both 160 18 142 28.0 [43]
Parra-Salcedo F Mexico IDF 2015 - 38.1 Both 160 18 142 18.0 [43]
Parra-Salcedo F Mexico NCEP-ATP III 2015 - 38.1 Both 160 18 142 24.0 [43]
Craciun L Romania IDF-AHA 2014 32–79 55.2 Both 51 7 77 19.0 10.52 82.47 [23]
Craciun L Romania NCEP-ATP III 2014 32–79 55.2 Both 51 7 77 23.0 [23]
Craciun L Romania IDF 2014 32–79 55.2 Both 51 7 77 18.0 [23]
Craciun L Romania AHA 2014 32–79 55.2 Both 51 7 77 14.0 [23]
Bilecik NA Turkey IDF 2014 24–65 52.0 Female 100 - 100 33.0 - 33.0 [44]
Bilecik NA Turkey NCEP-ATP III 2014 24–65 52.0 Female 100 - 100 27.0 - 27.0 [44]
Özmen M Turkey NCEP-ATP III 2014 - 51.0 Both 52 15 37 17.30 [45]
Özmen M Turkey WHO 2014 - 51.0 Both 52 15 37 28.80 [45]
Kumar BS India IDF 2014 ≥18 46.0 Both 54 6 48 29.0 [46]
Kumar BS India NCEP-ATP III 2014 ≥18 46.0 Both 54 6 48 31.0 [46]
Abourazzak FE Morocco IDF 2014 >16 49.0 Both 179 22 157 30.7 [26]
Abourazzak FE Morocco NCEP-ATP III 2014 >16 49.0 Both 179 22 157 29.0 [26]
Abourazzak FE Morocco AACE 2003 2014 >16 49.0 Both 179 22 157 24.6 [26]
Salinas MJH Argentina ATP III 2013 - 55.5 Both 409 69 340 30.0 62.0 23.8 [47]
Salinas MJH Argentina IDF 2013 - 55.5 Both 409 69 340 35.0 [47]
Abdul-Qahar Iraq NCEP-ATP III 2013 - 46.9 Both 203 41 162 51.2 12.0 92.0 [48]
Rostam S Morocco NCEP-ATP III-2004 2013 - 49.0 Both 120 10 110 30.8 10.0 32.7 [49]
Rostam S Morocco NCEP-ATP III-2001 2013 - 49.0 Both 120 10 110 24.6 [49]
Rostam S Morocco WHO 2013 - 49.0 Both 120 10 110 20.0 [49]
Rostam S Morocco IDF 2013 - 49.0 Both 120 10 110 48.6 [49]
Rostam S Morocco EGIR 2013 - 49.0 Both 120 10 110 18.0 [49]
Rostam S Morocco JC 2009 2013 - 49.0 Both 120 10 110 32.3 [49]
Lee SG Korea NCEP-ATP III 2013 22–76 50.6 Female 84 - 84 19.0 - 19.0 [34]
Ormseth MJ USA ATP III 2013 ≥18 54.0 Both 162 18 144 36.0 [50]
Karakoc Turkey IDF 2012 - 49.8 Both 54 7 47 42.6 [51]
Manka V Slovakia IDF 2012 ≥18 58.8 Both 87 4 83 48.3 [52]
Manka V Slovakia NCEP-ATP III 2012 ≥18 58.8 Both 87 4 83 44.8 [52]
Manka V Slovakia AHA/NHLBI 2012 ≥18 58.8 Both 87 4 83 47.1 [52]
Cunha VR Da Brazil NCEP-ATP III 2012 ≥18 56.8 Both 283 50 233 39.2 [53]
Goshayeshi L Iran NCEP-ATP III 2012 - 45.5 Both 120 14 106 45.2 [21]
Bkaer JF USA IDF 2012 18–85 49.5 Both 499 83 416 10.6 [54]
Crowson CS USA NCEP-ATP III 2011 ≥18 58.8 Both 232 58 174 33.0 36.0 32.0 [31]
Sahaberi M Iran IDF 2011 - 45.5 Both 120 14 106 30.8 28.6 41.5 [55]
Sahaberi M Iran NCEP-ATP III 2011 - 45.5 Both 120 14 106 45.2 28.6 37.7 [55]
Karimi M Iran NCEP 2011 ≥18 48.3 Female 92 - 92 27.2 - 27.2 [22]
Karimi M Iran WHO 2011 ≥18 48.3 Female 92 - 92 19.6 - 19.6 [22]
Mok CC Hong Kong JS 2009 2011 ≥18 53.3 Both 699 133 566 20.0 [56]
Dao HH Vietnam IDF 2010 26–73 56.3 Female 105 - 105 40.9 - 40.9 [57]
Dao HH Vietnam NCEP-ATP III 2004 2010 26–73 56.3 Female 105 - 105 32.4 - 32.4 [57]
Dao HH Vietnam NCEP-ATP III 2001 2010 26–73 56.3 Female 105 - 105 24.7 - 24.7 [57]
Dao HH Vietnam JS 2009 2010 26–73 56.3 Female 105 - 105 32.4 - 32.4 [57]
Dao HH Vietnam WHO 2010 26–73 56.3 Female 105 - 105 19.0 - 19.0 [57]
Dao HH Vietnam EGIR 2010 26–73 56.3 Female 105 - 105 16.2 - 16.2 [57]
Raterman H G Netherlands NCEP 2010 50–75 62.1 Both 236 79 157 19.9 [58]
Solomon A South Africa NCEP-ATP III 2010 - 27.2 Both 291 32 259 31.3 [59]
Solomon B South Africa NCEP-ATP III 2010 - 27.2 Both 335 65 270 20.3 [59]
Giles J USA NCEP-ATP III 2010 45–84 61 Both 131 51 80 36.0 [60]
Santos MJ Portugal ATP III 2010 ≥18 49.2 Female 98 98 25.5 [61]
Toms TE UK IDF 2009 55.5–69.6 63.1 Both 387 105 282 45.3 52.7 42.6 [25]
Toms TE UK NCEP-ATP III 2004 2009 55.5–69.6 63.1 Both 387 105 282 40.1 42.5 39.2 [25]
Toms TE UK NCEP-ATP III 2001 2009 55.5–69.6 63.1 Both 387 105 282 38.3 40.0 37.7 [25]
Toms TE UK WHO 2009 55.5–69.6 63.1 Both 387 105 282 19.4 25.5 17.2 [25]
Toms TE UK EGIR 2009 55.5–69.6 63.1 Both 387 105 282 12.1 22.6 8.2 [25]
Chung CP USA WHO 2008 ≥18 59 Both 66 18 48 42.0 [29]
Zonana-Nacach A Mexico NCEP-ATP III 2008 - 42.9 Both 107 18.7 [30]
Karvounaris SA Greece ATP III 2007 ≥18 63.0 Both 200 53 147 44.0 39.6 45.6 [32]
Montagna G La Italy NCEP-ATP III 2007 - 53.8 Both 45 3 42 55.5 [62]